Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Xiao-I Corporation (AIXI) and Encourages Investors to Seek Compensation for Alleged Wrongdoings
Bronstein, Gewirtz & Grossman, is investigating potential claims against Xiao-I (NASDAQ:AIXI) on behalf of investors who purchased the company's securities. The investigation focuses on the significant drop in Xiao-I's American depositary shares (ADSs) price since its initial public offering (IPO) on March 8, 2023, where 5.7 million ADSs were sold at $6.80 per share. Investors are encouraged to participate in the investigation by visiting bgandg.com/AIXI. The law firm operates on a contingency fee basis, seeking reimbursement for expenses and attorneys' fees only if successful. Bronstein, Gewirtz & Grossman, has a track record of recovering substantial amounts for investors in securities fraud class actions and shareholder derivative suits.
Bronstein, Gewirtz & Grossman sta indagando su potenziali reclami contro Xiao-I (NASDAQ:AIXI) per conto degli investitori che hanno acquistato i titoli della società. L'indagine si concentra sul significativo calo del prezzo delle azioni di deposito americane (ADS) di Xiao-I dall'offerta pubblica iniziale (IPO) dell'8 marzo 2023, in cui sono state vendute 5,7 milioni di ADS a 6,80 dollari per azione. Si incoraggiano gli investitori a partecipare all'indagine visitando bgandg.com/AIXI. Lo studio legale opera su base di commissione contro il successo, cercando il rimborso delle spese e delle spese legali solo in caso di successo. Bronstein, Gewirtz & Grossman ha una solida esperienza nel recupero di somme consistenti per gli investitori in azioni legali per frode sui titoli e in azioni derivativi per gli azionisti.
Bronstein, Gewirtz & Grossman está investigando posibles reclamos contra Xiao-I (NASDAQ:AIXI) en nombre de los inversores que compraron valores de la empresa. La investigación se centra en la caída significativa del precio de las acciones de depósito americanas (ADS) de Xiao-I desde su oferta pública inicial (IPO) el 8 de marzo de 2023, cuando se vendieron 5,7 millones de ADS a $6.80 por acción. Se anima a los inversores a participar en la investigación visitando bgandg.com/AIXI. El bufete de abogados opera con una base de honorarios de éxito, buscando reembolso por gastos y honorarios de abogados solo si tiene éxito. Bronstein, Gewirtz & Grossman tiene un historial de recuperación de cantidades sustanciales para los inversores en acciones colectivas por fraude de valores y en demandas derivativas de accionistas.
Bronstein, Gewirtz & Grossman은 Xiao-I(NASDAQ:AIXI)에 대한 잠재적인 청구를 조사하고 있습니다 투자한 주식에 대해. 이 조사는 Xiao-I의 미국 예탁 주식(ADS) 가격이 2023년 3월 8일 상장 이후 5.7백만 ADS가 주당 $6.80에 판매되었던 것과 비교하여 크게 하락한 것에 초점을 맞추고 있습니다. 투자자들은 bgandg.com/AIXI를 방문하여 조사에 참여할 것을 권장합니다. 법률 사무소는 성공 시에만 비용 및 변호사 수임료를 환급받기 위한 성과 수수료 방식으로 운영됩니다. Bronstein, Gewirtz & Grossman은 증권 사기 집단 소송 및 주주 파생 소송에서 투자자들을 위해 상당한 금액을 회수한 경력이 있습니다.
Bronstein, Gewirtz & Grossman investiguer des réclamations potentielles contre Xiao-I (NASDAQ:AIXI) au nom des investisseurs qui ont acheté des titres de la société. L'enquête se concentre sur la chute significative du prix des actions de dépôt américaines (ADS) de Xiao-I depuis l'introduction en bourse (IPO) du 8 mars 2023, où 5,7 millions d'ADS ont été vendues à 6,80 $ l'action. Les investisseurs sont encouragés à participer à l'enquête en visitant bgandg.com/AIXI. Le cabinet d'avocats fonctionne sur la base d'honoraires de succès, cherchant à être remboursé des frais et des honoraires d'avocat uniquement en cas de succès. Bronstein, Gewirtz & Grossman a un bilan de récupération de montants substantiels pour les investisseurs dans des actions collectives en fraude de valeurs mobilières et dans des actions dérivées des actionnaires.
Bronstein, Gewirtz & Grossman führt Ermittlungen zu potenziellen Ansprüchen gegen Xiao-I (NASDAQ:AIXI) im Namen von Investoren durch, die Wertpapiere des Unternehmens erworben haben. Die Untersuchung konzentriert sich auf den erheblichen Rückgang des Preises der amerikanischen Depotanteile (ADS) von Xiao-I seit dem Börsengang (IPO) am 8. März 2023, bei dem 5,7 Millionen ADS zu je 6,80 $ verkauft wurden. Investoren werden ermutigt, an den Ermittlungen teilzunehmen, indem sie bgandg.com/AIXI besuchen. Die Kanzlei arbeitet auf Erfolgsbasis und strebt eine Erstattung von Kosten und Anwaltsgebühren nur im Erfolgsfall an. Bronstein, Gewirtz & Grossman hat eine nachgewiesene Erfolgsbilanz in der Rückgewinnung substantieller Beträge für Investoren in Sammelklagen wegen Wertpapierbetrugs und in Aktionärsderivatsklagen.
- None.
- Significant drop in Xiao-I's ADS price since IPO, potentially damaging investors
- Ongoing investigation into potential claims against Xiao-I
- Possible securities fraud or shareholder rights violations
This investigation into Xiao-I (AIXI) raises significant red flags for investors. The substantial drop in ADS price since the IPO suggests potential misrepresentation or omission of material facts during the offering. While the specifics of the alleged wrongdoings aren't disclosed, such investigations often lead to class action lawsuits and regulatory scrutiny.
Investors should be cautious as this could indicate deeper financial or operational issues within the company. The involvement of a reputable law firm like Bronstein, Gewirtz & Grossman adds credibility to the concerns. If wrongdoing is proven, it could result in financial penalties and reputational damage for Xiao-I, potentially further impacting stock value.
The investigation into Xiao-I's IPO raises serious concerns about the company's financial health and transparency. The significant drop in ADS price from the
Moreover, legal proceedings could result in substantial financial liabilities and divert management's attention from core operations. Investors should closely monitor the company's upcoming financial disclosures and any updates regarding the investigation. The potential for a class action lawsuit also introduces the risk of dilution if the company needs to raise capital to cover legal expenses or settlements.
NEW YORK CITY, NY / ACCESSWIRE / August 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Xiao-I Corporation ("Xiao-I" or "the Company") (NASDAQ:AIXI). Investors who purchased Xiao-I securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AIXI.
Investigation Details
On or around March 8, 2023, Xiao-I conducted its initial public offering ("IPO"), selling 5.7 million American depositary shares ("ADSs") at
What's Next?
If you are aware of any facts relating to this investigation or purchased Xiao-I securities, you can assist this investigation by visiting the firm's site: bgandg.com/AIXI. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on accesswire.com
FAQ
What is the purpose of the investigation against Xiao-I (AIXI)?
When did Xiao-I (AIXI) conduct its IPO and at what price?
How can investors participate in the investigation against Xiao-I (AIXI)?
What are the potential outcomes for investors in the Xiao-I (AIXI) investigation?
